Key result
Probucol reduced HDL-C and human apo A-I by decreasing apo A-I transport rate and increasing HDL cholesteryl ester fractional catabolic rate.
Answers are grounded in this paper and cite their sources.
Probucol effects on lipoprotein metabolism were determined in control and human apolipoprotein A-I transgenic (HuAITg) mice. In control mice, probucol reduced total cholesterol from 67 +/- 2 to 25 +/- 2 mg/dl by reducing high density lipoprotein (HDL) cholesterol from 46 +/- 20 to 14 +/- 1 mg/dl and low density lipoprotein (LDL) cholesterol from 11 +/- 1 to 5 +/- 1 mg/dl. Apolipoprotein (apo) A-I levels were reduced from 122 +/- 8 to 56 +/- 5 mg/dl. In HuAITg mice, probucol reduced total cholesterol from 121 +/- 5 to 77 +/- 3 mg/dl by reducing HDL cholesterol from 84 +/- 4 to 56 +/- 3 mg/dl and LDL cholesterol from 19 +/- 2 to 11 +/- 2 mg/dl. Human apo A-I levels were reduced from 267 +/- 13 to 144 +/- 12 mg/dl and mouse apo A-I levels from 18 +/- 2 to 9 +/- 2 mg/dl. Control animals have primarily a monodisperse HDL with a particle diameter of 10 nm. Probucol did not appear to change the particle size distribution in the control animals. The HuAITg mice have a polydisperse HDL with particle diameters of 10.1 and 8.5 nm. Probucol treatment of these animals resulted in HDL with particle diameters of 9.4 and 8.5 nm, apparently reducing the size of the larger particles. In vivo turnover studies revealed that the reduction in apo A-I was primarily due to a decrease in transport rate, whereas the reduction in HDL cholesterol was primarily due to an increase in HDL cholesteryl ester fractional catabolic rate.(ABSTRACT TRUNCATED AT 250 WORDS)
No takes yet. Share an insight, caveat, or question.
Hayek et al. (1991) studied Lipoprotein metabolism in control and human apolipoprotein A-I transgenic (HuAITg) mice. Probucol vs. Untreated/baseline control and HuAITg mice was evaluated on Lipoprotein and apolipoprotein A-I levels, HDL particle size, apo A-I transport rate, and HDL cholesteryl ester fractional catabolic rate. Probucol reduced HDL-C and human apo A-I by decreasing apo A-I transport rate and increasing HDL cholesteryl ester fractional catabolic rate.
Synapse has enriched 10 related papers. Consider them for comparative context: